Melanoma News and Research

Latest Melanoma News and Research

AAD applauds California for prohibiting indoor tanning device use among youngsters

Today California Governor Edmund G. Brown signed a bill into law that will prohibit the use of indoor tanning devices for all Californians under the age of 18.

10 Oct 2011

Scientists identify first DNA faults linked to melanoma

Cancer Research UK scientists have discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour, according to research published in Nature Genetics today.

10 Oct 2011

Study identifies three new chromosomal regions implicated in susceptibility to melanoma

The genomic analysis technologies enable the study of genetic factors related to numerous diseases. In few areas this researches brought such a big and useful volume of information as in the case of melanoma.

10 Oct 2011

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.

7 Oct 2011

Vitamin D deficiency might be common in fair skinned people: Study

The British study suggests that pale people tend to be deficient in the “sunshine” vitamin and that without supplements they're unlikely to get their levels up without getting sunburned. That can put them at risk for bone loss, heart disease, and poorer survival from breast cancer, according to the study's authors.

5 Oct 2011

Latest findings on cancer to be presented at 10th AACR international conference

What: The 10th AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists to share the latest findings in genetics, chemoprevention and lifestyle choices that may prevent cancer.

4 Oct 2011

Study: Fair-skinned people may need to take vitamin D supplements

Fair-skinned people who burn quickly in the sun may need to take supplements to ensure they get the right amount of vitamin D, new research finds.

4 Oct 2011

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune, the T cell therapy company pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.

3 Oct 2011

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who've provided an invaluable contribution to medical science and healthcare.

30 Sep 2011

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin Therapeutics Inc. today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company's leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer.

30 Sep 2011

Immunotherapeutics for treatment of metastatic melanoma

A new cancer research program at Loyola University Chicago Stritch School of Medicine will develop therapies designed to turn patients' own immune systems into potent weapons against cancer.

30 Sep 2011

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.

30 Sep 2011

New research on public perceptions about cancer

New research on public perceptions about cancer reveals that 50-year-old ideas still hold sway while many current lifestyle messages are not getting through.

28 Sep 2011

Raised blood pressure may higher risk of cancer, death

Raised blood pressure is linked to a higher risk of developing cancer or dying from the disease according to the findings of the largest study to date to investigate the association between the two conditions.

27 Sep 2011

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

IsoRay, a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that doctors at New York Presbyterian Hospital/ Weill Cornell Medical Center have performed the world's first treatment of metastasized brain cancer using IsoRay's Cesium-131 brachytherapy seeds.

26 Sep 2011

Percutaneous hepatic perfusion extends survival time for melanoma patients

Melanoma of the eye frequently spreads to the liver and, once this has happened, there is no effective treatment and patients die within an average of two to four months. Only about one in ten patients live for a year. Now, final results from a phase III study have demonstrated that a new treatment significantly extends the time patients can live without the disease progressing.

26 Sep 2011

Adeno-associated virus type 2 kills human breast cancer cells in lab

A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.

23 Sep 2011

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Bristol-Myers Squibb Company and Ono Pharmaceutical Co., Ltd., today announced an agreement to expand Bristol-Myers Squibb's territorial rights to develop and commercialize the anti-PD-1 antibody known as BMS-936558/ONO-4538, and to create a strategic alliance for the co-development and co-commercialization of ORENCIA in Japan.

21 Sep 2011

Beta-blocker drugs may improve survival time for melanoma patients

Beta-blocker drugs, commonly used to treat high blood pressure, may also play a major role in slowing the progression of certain serious cancers, based on a new study.

21 Sep 2011

Melanoma News and Research

Latest Melanoma News and Research

AAD applauds California for prohibiting indoor tanning device use among youngsters

Scientists identify first DNA faults linked to melanoma

Study identifies three new chromosomal regions implicated in susceptibility to melanoma

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Vitamin D deficiency might be common in fair skinned people: Study

Latest findings on cancer to be presented at 10th AACR international conference

Study: Fair-skinned people may need to take vitamin D supplements

Adaptimmune announces new board appointments as clinical programmes get underway

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Immunotherapeutics for treatment of metastatic melanoma

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

New research on public perceptions about cancer

Raised blood pressure may higher risk of cancer, death

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

Percutaneous hepatic perfusion extends survival time for melanoma patients

Adeno-associated virus type 2 kills human breast cancer cells in lab

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Beta-blocker drugs may improve survival time for melanoma patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in